Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model
- PMID: 11502511
- PMCID: PMC90674
- DOI: 10.1128/AAC.45.9.2436-2440.2001
Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model
Abstract
An in vitro kinetic model was used to study the relation between pharmacokinetic and pharmacodynamic (PK-PD) parameters for antimicrobial effect, e.g., the time above MIC (T>MIC), maximum concentration in serum (C(max)), and area under the concentration-time curve (AUC). Streptococcus pyogenes and Escherichia coli were exposed to cefotaxime, and the activity of amoxicillin against four strains of Streptococcus pneumoniae with different susceptibilities to penicillin was studied. The drug elimination rate varied so that the T>MIC ranged from 20 to 100% during 24 h, while the AUC and/or the initial concentration (C(max)) were kept constant. For S. pyogenes and E. coli, the maximal antimicrobial effect (E(max)) at 24 h occurred when the antimicrobial concentration exceeded the MIC for 50 and 80% of the strains tested, respectively. The penicillin-susceptible pneumococci (MIC, 0.03 mg/liter) and the penicillin-intermediate strain (MIC, 0.25 mg/liter) showed maximal killing by amoxicillin at a T>MIC of 50%. For a strain for which the MIC was 2 mg/liter, C(max) needed to be increased to achieve the E(max). Under the condition that C(max) was 10 times the MIC, E(max) was obtained at a T>MIC of 60%, indicating that C(max), in addition to T>MIC, may be an important parameter for antimicrobial effect on moderately penicillin-resistant pneumococci. For the strain for which the MIC was 4 mg/liter, the reduction of bacteria varied from -0.4 to -3.6 log(10) CFU/ml at a T>MIC of 100%, despite an initial antimicrobial concentration of 10 times the MIC. Our studies have shown that the in vitro kinetic model is a useful complement to animal models for studying the PK-PD relationship for antimicrobial effect of antibiotics.
Figures




Similar articles
-
Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.Antimicrob Agents Chemother. 1997 Jun;41(6):1389-91. doi: 10.1128/AAC.41.6.1389. Antimicrob Agents Chemother. 1997. PMID: 9174206 Free PMC article. Clinical Trial.
-
Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.Antimicrob Agents Chemother. 1996 Dec;40(12):2904-6. doi: 10.1128/AAC.40.12.2904. Antimicrob Agents Chemother. 1996. PMID: 9124866 Free PMC article.
-
Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):75-80. doi: 10.1007/s10096-007-0402-5. Epub 2007 Oct 18. Eur J Clin Microbiol Infect Dis. 2008. PMID: 17943330
-
How can we predict bacterial eradication?Int J Infect Dis. 2003 Mar;7 Suppl 1:S13-20. doi: 10.1016/s1201-9712(03)90066-x. Int J Infect Dis. 2003. PMID: 12839703 Review.
-
The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.Dan Med Bull. 2000 Nov;47(5):313-27. Dan Med Bull. 2000. PMID: 11155659 Review.
Cited by
-
Editorial: Antibiotics Special Issue on Pharmacokinetic/Pharmacodynamic Models of Antibiotics.Antibiotics (Basel). 2022 Nov 3;11(11):1540. doi: 10.3390/antibiotics11111540. Antibiotics (Basel). 2022. PMID: 36358195 Free PMC article.
-
Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center.Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00505-18. doi: 10.1128/AAC.00505-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29914948 Free PMC article. Clinical Trial.
-
Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.J Inflamm (Lond). 2014 Feb 24;11(1):5. doi: 10.1186/1476-9255-11-5. J Inflamm (Lond). 2014. PMID: 24565171 Free PMC article.
-
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.Antimicrob Agents Chemother. 2007 Jan;51(1):128-36. doi: 10.1128/AAC.00604-06. Epub 2006 Oct 23. Antimicrob Agents Chemother. 2007. PMID: 17060524 Free PMC article.
-
Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies.PLoS Comput Biol. 2017 Jan 6;13(1):e1005321. doi: 10.1371/journal.pcbi.1005321. eCollection 2017 Jan. PLoS Comput Biol. 2017. PMID: 28060813 Free PMC article.
References
-
- Azoulay-Dupuis E, Moine P, Bedos J P, Rieux V, Vallee E. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis and tolerance properties of the strains. Antimicrob Agents Chemother. 1996;40:941–946. - PMC - PubMed
-
- Barry B, Gehanno P, Blumen M, Boucot I. Clinical outcome of acute otitis media caused by pneumococci with decreased susceptibility to penicillin. Scand J Infect Dis. 1994;26:446–452. - PubMed
-
- Cars O, Henning C, Holm S E. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scand J Infect Dis. 1981;13:69–74. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases